SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-191098
Filing Date
2020-07-10
Accepted
2020-07-10 16:06:40
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d13608ds3.htm S-3 416821
2 EX-1.2 d13608dex12.htm EX-1.2 220823
3 EX-3.2 d13608dex32.htm EX-3.2 164953
4 EX-4.3 d13608dex43.htm EX-4.3 33459
5 EX-4.4 d13608dex44.htm EX-4.4 250540
6 EX-5.1 d13608dex51.htm EX-5.1 35463
7 EX-23.1 d13608dex231.htm EX-23.1 2212
8 GRAPHIC g13608g17p05.jpg GRAPHIC 43963
9 GRAPHIC g13608g23q04.jpg GRAPHIC 34816
10 GRAPHIC g13608g28s11.jpg GRAPHIC 30264
11 GRAPHIC g13608g52o56.jpg GRAPHIC 12420
  Complete submission text file 0001193125-20-191098.txt   1274121
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-239801 | Film No.: 201023238
SIC: 2834 Pharmaceutical Preparations